S-1

Company

ENDRA Life Sciences Inc.

Filed

March 30, 2023

Accession Number

0001654954-23-003937

An S-1 is a registration statement filed by a company preparing for its initial public offering (IPO). It discloses the business model, financials, risk factors, and use of proceeds. Learn more about S-1 filings →